Luliconazole, a highly effective imidazole, against Fusarium species complexes
- 6 April 2020
- journal article
- research article
- Published by Springer Nature in Medical Microbiology and Immunology
- Vol. 209 (5) , 603-612
Abstract
Luliconazole is a new antifungal that was primarily used for the treatment of dermatophytosis. However, some studies have shown that it has excellent efficacy against Aspergillus and Candida species in vitro. The present study aimed to evaluate of luliconazole activity against some Fusarium species complex isolates. In this study, 47 isolates of Fusarium were tested against several antifungals including luliconazole. All species were identified using morphology features, and PCR sequencing and antifungal susceptibility were performed according to CLSIM38 A3 guideline. Our results revealed that luliconazole has a very low minimum inhibitory concentration value (0.0078–1 µg/ml) in comparison with other tested antifungals. Amphotericin B had a poor effect with a high MIC90 (64 µg/ml), followed by terbinafine (32 µg/ml), posaconazole (16 µg/ml), caspofungin (16 µg/ml), voriconazole (4 µg/ml), and itraconazole (4 µg/ml). Overall, our findings indicated that luliconazole has great activity against environmental and clinical Fusarium species complexes in comparison to tested antifungals.Keywords
Funding Information
- This study supported by Infectious and Tropical Diseases Research Centre, Health Research Institute, Ahvaz Jundishapur University of Medical Sciences (OG: 9722)
This publication has 49 references indexed in Scilit:
- In-vitro antifungal susceptibility testing of lanoconazole and luliconazole against Aspergillus flavus as an important agent of invasive aspergillosisJournal of Infection and Chemotherapy, 2019
- Efficacy of Luliconazole Against Broad-Range Filamentous Fungi Including Fusarium solani Species Complex Causing Fungal KeratitisCornea, 2018
- Luliconazole, a new antifungal against Candida species isolated from different sourcesJournal of Medical Mycology, 2018
- In Vitro Activities of Luliconazole, Lanoconazole, and Efinaconazole Compared with Those of Five Antifungal Drugs against Melanized Fungi and RelativesAntimicrobial Agents and Chemotherapy, 2017
- Luliconazole, an alternative antifungal agent against Aspergillus terreusJournal of Medical Mycology, 2017
- Potent Activities of Novel Imidazoles Lanoconazole and Luliconazole against a Collection of Azole-Resistant and -Susceptible Aspergillus fumigatus StrainsAntimicrobial Agents and Chemotherapy, 2016
- New Antifungal Agents and New Formulations Against DermatophytesMycopathologia, 2016
- Luliconazole Demonstrates Potent In Vitro Activity against Dermatophytes Recovered from Patients with OnychomycosisAntimicrobial Agents and Chemotherapy, 2014
- Safety and Tolerability of Luliconazole Solution 10-Percent in Patients with Moderate to Severe Distal Subungual OnychomycosisAntimicrobial Agents and Chemotherapy, 2013
- A comparative clinical study between 2 weeks of luliconazole 1% cream treatment and 4 weeks of bifonazole 1% cream treatment for tinea pedisMycoses, 2006